Last reviewed · How we verify
A Study of KL130008 in Adults With Severe Alopecia Areata
The purpose of this study is to assess KL130008 is safe and effective in adults with severe alopecia areata
Details
| Lead sponsor | Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. |
|---|---|
| Phase | PHASE2 |
| Status | UNKNOWN |
| Enrolment | 176 |
| Start date | Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Alopecia Areata
Interventions
- KL130008/Placebo
Countries
China